US Patent Issued to Skyhawk Therapeutics on Dec. 30 for "Methods and compositions for modulating splicing" (Connecticut, Massachusetts Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,460, issued on Dec. 30, was assigned to Skyhawk Therapeutics Inc. (Waltham, Mass.).

"Methods and compositions for modulating splicing" was invented by Michael Luzzio (Noank, Conn.) and Brian Lucas (Arlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions."

The patent was filed on Aug. 2, 2021, under Application No. 17/391,620.

*For further information, including images, charts and ...